Fixed Ribbon

Talk to a doctor online
about an AcipHex®
prescription with LifeMD

Important Safety Information
See If You Qualify Get Started Now

LifeMD can connect you with a medical provider who can write a prescription for FDA-approved AcipHex®, if appropriate.

Don’t let acid reflux hold you back. AcipHex® has been providing relief for more than 20 years and can help cool the symptoms associated with acid reflux disease, such as heartburn.

Important Safety Information
  • Proven Clinical Results

    AcipHex® is approved by the FDA as an effective treatment for stomach acid related diseases, such as acid reflux.

  • Works at the Source

    AcipHex® is a proton pump inhibitor, which means it works to stop the root of your acid reflux, by lowering stomach acid production.

  • Convenient

    AcipHex® has partnered with LifeMD, a telehealth company that connects you with doctors who can write prescriptions online.

Get Started

Limited Time Offer: Save 50% on your prescription consultation.

AcipHex® Copay Savings Program

With the AcipHex® Copay Savings Card, you may pay as little as $5.00 for your brand-name AcipHex® prescription.

Woodward Pharma is a patient-first company, continuously developing access and affordability programs to make sure that AcipHex® is easily accessible for those who need it.

Get Your AcipHex® Savings Card Today >

How LifeMD Works.

We’ve taken the complication and time out of healthcare.
LifeMD makes it easy to gain access to the medications you need. Getting help is fast, simple, and affordable.



Get Started

Limited Time Offer: Save 50% on your prescription consultation.

FDA-Approved AcipHex®
now available from your home.

Clinically proven results.
AcipHex® has been proven to reduce levels of stomach acid.

Trusted for Decades

For over 20 years, AcipHex® has helped patients cool down their acid reflux by lowering stomach acid levels.

FDA-Approved

AcipHex® is an FDA-approved medication, which means it passed rigorous safety and efficacy testing in clinical trials.

Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use AcipHex® for a condition for which it was not prescribed. Do not give AcipHex® to other people, even if they have the same problem you have. It may harm them.

Get Started

Accessing AcipHex®

has never been easier with LifeMD

Thanks to the power of telehealth

Telehealth is dramatically changing the way we think about and access healthcare. Now you can skip waiting for physical appointments for treatment, while saving time and money all along the way. Start treatment by booking your appointment today, it’ll take less than 2 minutes!

Book your appointment

Cool down your acid reflux with AcipHex®
by booking a doctor consultation with LifeMD.
Save 50% off your consultation today,
just pay $20!

Book your appointment

WW-ACI-USA-0034

SHOW MORE
SHOW LESS

IMPORTANT SAFETY INFORMATION AND INDICATIONS

Select Safety Information for ACIPHEX® (rabeprazole sodium) delayed-release tablets

ACIPHEX® has a well-established safety profile. The most common side effect possibly related to ACIPHEX® is headache. Symptom relief does not rule out other serious stomach conditions. Patients on warfarin or other medications may need to be monitored more closely by their doctor. The risk of side effects goes up over time. Ask your doctor how long you should take this medication.

INDICATIONS AND USAGE
ACIPHEX® is a proton pump inhibitor (PPI), and is used for the treatment of persistent, frequent (2 or more days a week) heartburn and other symptoms associated with acid reflux disease

Indications For adults:

Indications For Adolescents 12 and Older:

DOSAGE AND ADMINISTRATION
20 mg ACIPHEX® tablets should be taken with water. Dosage is determined by your doctor during prescription. Healthcare Professionals should consult the full ACIPHEX® Dosing Information

WARNINGS AND PRECAUTIONS

CONTRAINDICATIONS
People should not take ACIPHEX® if:

ADVERSE REACTIONS
Most common adverse reactions in adults (>2%) are pain, pharyngitis, flatulence, infection, and constipation.

Most common adverse reactions in adolescents (≥2%) are headache, diarrhea, nausea, vomiting, and abdominal pain.

To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

IMPORTANT SAFETY INFORMATION AND INDICATIONS

Select Safety Information for AcipHex® (rabeprazole sodium) delayed-release tablets

AcipHex® has a well-established safety profile. The most common side effect possibly related to AcipHex® is headache. Symptom relief does not rule out other serious stomach conditions. Patients on warfarin or other medications may need to be monitored more closely by their doctor. The risk of side effects goes up over time. Ask your doctor how long you should take this medication.

INDICATIONS AND USAGE

AcipHex® is a proton pump inhibitor (PPI), and is used for the treatment of persistent, frequent (2 or more days a week) heartburn and other symptoms associated with acid reflux disease.

Indications For adults:

  • Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD)
  • Maintenance of Healing of Erosive or Ulcerative GERD
  • Treatment of Symptomatic GERD
  • Healing of Duodenal Ulcers
  • Helicobacter pylori Eradication to Reduce Risk of Duodenal Ulcer Recurrence
  • Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome

Indications For Adolescents 12 and Older:

  • Short-term Treatment of Symptomatic GERD

DOSAGE AND ADMINISTRATION

20 mg AcipHex® tablets should be taken with water. Dosage is determined by your doctor during prescription. Healthcare Professionals should consult the full AcipHex® Dosing Information

WARNINGS AND PRECAUTIONS

  • Gastric Malignancy: In adults, symptomatic response to therapy with rabeprazole does not preclude the presence of gastric malignancy. Consider additional follow-up and diagnostic testing.
  • Use with Warfarin: Monitor for increases in INR and prothrombin time.
  • Acute Tubulointerstitial Nephritis: Discontinue treatment and evaluate patients.
  • Clostridium difficile–Associated Diarrhea: PPI therapy may be associated with increased risk of.
  • Bone Fracture: Long-term and multiple daily dose PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine.
  • Cutaneous and Systemic Lupus Erythematosus: Mostly cutaneous, new onset or exacerbation of existing disease; discontinue AcipHex® and refer to specialist for evaluation.
  • Cyanocobalamin (Vitamin B-12) Deficiency: Daily long-term use (e.g., longer than 3 years) may lead to malabsorption or a deficiency of cyanocobalamin.
  • Hypomagnesemia: Reported rarely with prolonged treatment with PPIs.
  • Interaction with Methotrexate: Concomitant use with PPIs may elevate and/or prolong serum concentrations of methotrexate and/or its metabolite, possibly leading to toxicity. With high dose methotrexate administration, consider a temporary withdrawal of AcipHex® delayed-release tablets.
  • Fundic Gland Polyps: Risk increases with long-term use, especially beyond one year. Use the shortest duration of therapy.

CONTRAINDICATIONS
People should not take AcipHex® if:

  • They are allergic to AcipHex®, rabeprazole, or any of its ingredients
  • They are on certain (rilpivirine-containing) therapies for HIV/AIDs
  • They are on certain antibiotic treatments, such as clarithromycin and amoxicillin

ADVERSE REACTIONS

Most common adverse reactions in adults (>2%) are pain, pharyngitis, flatulence, infection, and constipation.

Most common adverse reactions in adolescents (≥2%) are headache, diarrhea, nausea, vomiting, and abdominal pain.

To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.